Op 21 november 2024 organiseerde Breakthrough T1D het evenement ‘Onderzoek naar Doorbraak.’ We kijken terug op een mooie...
Categorie - Updates
Intensive Glucose Lowering and Its Effects on Vascular Events and...
OBJECTIVETo compare the vascular effects of pursuing more versus less glucose lowering in patients with younger or older age...
Use of High-Risk Glucose-Lowering Agents in Older U.S. Adults With...
National Heart, Lung, and Blood Institute10.13039/1000000505T32HL007024K23 HL153774K24 HL152440National Institute of...
Metformin Treatment With or Without Mediterranean Diet for the...
OBJECTIVEThe Metformin and Dietary Restriction to Prevent Age-Related Morbid Events in People With Metabolic Syndrome...
Genetic Discovery and Risk Prediction for Type 1 Diabetes in...
OBJECTIVEMore than 10% of patients with type 1 diabetes (T1D) do not have high-risk HLA-DR3 or -DR4 haplotypes with distinct...
Compounded GLP-1 and Dual GIP/GLP-1 Receptor Agonists: A Statement...
The use of glucagon-like peptide 1 receptor agonist (GLP-1 RA) and dual glucose-dependent insulinotropic polypeptide (GIP)...
Continuous Glucose Monitor Accuracy for Diabetes Management in...
OBJECTIVEThe adoption of continuous glucose monitors (CGMs) in inpatient settings in the pediatric population has been slow...
Diabetes Body Project: Acute Effects of an Eating Disorder Prevention...
OBJECTIVEYoung women with type 1 diabetes are at risk to develop eating disorders (ED). We evaluated a novel ED prevention...
Cutaneous Carbonyl Stress Is Associated With Nerve Dysfunction in...
OBJECTIVEEndogenous carbonyl stress leads to the formation of advanced glycation end products (AGEs). AGEs represent a...
Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With...
OBJECTIVETo evaluate the association of four bone metabolism biomarkers (osteoprotegerin, osteopontin, sclerostin, and...